TREE NEWS update: Researchers at the University of Manchester published a paper in the British Journal of Cancer saying that three-dimensional tumor models built in the lab with biomaterials, which mimic the real tumor environment in the human body, can help accelerate anticancer drug development. The researchers also said the technology still cannot replicate the body’s full complexity, so animal testing will remain important for disease research and for assessing drug efficacy and safety for the foreseeable future.
3D Tumor Models Said to Speed Up Cancer Drug Development
AI take
The significance here is less the lab technique than the stated limit: a 3D model that improves on flat cell cultures still cannot stand in for whole-body complexity, so animal testing keeps its role in efficacy and safety assessment. That framing matters for anyone tracking how preclinical evidence is generated and where replacement methods are credible. Whether such biomaterial-based models shift from academic publication to routine use in development pipelines is the open question.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
1h ago
SK Group’s Ulsan AI Data Center Capacity Expands to Nearly 900 MW
1h ago
Hyundai to launch in-house Level 2++ driving system in H2 2029
2h ago
China’s National Data Administration Holds Symposium on Embodied AI
3h ago
China Telecom GM Liu Guiqing Calls for Deeper Computing-Power Coordination
3h ago
China’s national computing platform achieves unified monitoring of compute resources
6h ago
BRICS New Delhi Declaration Backs AI Cooperation, Smart Manufacturing Working Groups